[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Abraham Hulst, MD, PhD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100565160","postoperative-basal-bolus-or-sliding-scale-insulin-regimen-in-dm2-and-its-effect-on-surgical-site-infections-100565160",false,"NCT06638567","Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.","Postoperative Glucose Control with a Basal Bolus Versus Sliding Scale Insulin Regimen and Its Effect on the Incidence of Surgical Site Infections in People with Type 2 Diabetes Mellitus.","GUIDE","Inclusion Criteria:\n\n* Patients aged 18 or older\n* Diagnosed with type 2 diabetes mellitus\n* Undergoing gastointestinal or vascular surgery\n* Admitted to one of the participating surgical wards\n* Expected duration of stay at least one overnight stay\n* Willing and able to provide informed consent\n\nExclusion Criteria:\n\n* Diagnosed with type 1 diabetes mellitus\n* Female of child-bearing potential who is pregnant or breastfeeding.\n* Undergoing complete pancreatectomy\n* Undergoing bariatric surgery\n* Patients using a continuous insulin pump at home\n* Patients undergoing a necrotectomy\u002Fwound debridement from a pre-existent wound.","ALL","18 Years",{"count":20,"type":21},1008,"ESTIMATED","INTERVENTIONAL",[24],"NA","A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol\u002FL, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.",[27,28],"Diabetes Mellitus, Type 2","Surgical Site Infection",[30,31,32,33,34],"Diabetes Mellitus","Basal bolus regimen","Surgical site infections","Sliding scale","Insulin regimen","RECRUITING","2025-01-28",{"date":38,"type":39},"2025-01-30","ACTUAL",{"date":41,"type":39},"2025-01-03",{"date":43,"type":21},"2027-09",{"name":45,"class":46},"Abraham Hulst, MD, PhD","OTHER",""]